Packer, M. Et Al. 2015. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. CIRCULATION , vol.131, no.1 , 54-61.

Packer, M., McMurray, J. J. V., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., ... Rouleau, J. L.(2015). Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. CIRCULATION , vol.131, no.1, 54-61.

Packer, Hasan Et Al. "Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure," CIRCULATION , vol.131, no.1, 54-61, 2015

Packer, Hasan Et Al. "Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure." CIRCULATION , vol.131, no.1, pp.54-61, 2015

Packer, M. Et Al. (2015) . "Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure." CIRCULATION , vol.131, no.1, pp.54-61.

@article{article, author={Hasan KUDAT Et Al. }, title={Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure}, journal={CIRCULATION}, year=2015, pages={54-61} }